In 2022, over 62 million doses of human papillomavirus (HPV) vaccines were released in China. Thanks to the company's more effective 4-valent and 9-valent HPV vaccines, Merck Sharp & Dohme held almost three quarters of the market share, based on the total contract price of lots released. The Chinese pharmaceutical company Beijing Wantai was also gaining ground in the local market. HPV vaccines are highly effective in preventing cervical cancer and anal cancer.
Market share of major human papillomavirus (HPV) vaccine manufacturers in China in 2022, based on lot release contract price
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (November 9, 2023). Market share of major human papillomavirus (HPV) vaccine manufacturers in China in 2022, based on lot release contract price [Graph]. In Statista. Retrieved December 19, 2024, from https://www.statista.com/statistics/1313427/china-hpv-vaccine-producer-market-share/
Statista. "Market share of major human papillomavirus (HPV) vaccine manufacturers in China in 2022, based on lot release contract price." Chart. November 9, 2023. Statista. Accessed December 19, 2024. https://www.statista.com/statistics/1313427/china-hpv-vaccine-producer-market-share/
Statista. (2023). Market share of major human papillomavirus (HPV) vaccine manufacturers in China in 2022, based on lot release contract price. Statista. Statista Inc.. Accessed: December 19, 2024. https://www.statista.com/statistics/1313427/china-hpv-vaccine-producer-market-share/
Statista. "Market Share of Major Human Papillomavirus (Hpv) Vaccine Manufacturers in China in 2022, Based on Lot Release Contract Price." Statista, Statista Inc., 9 Nov 2023, https://www.statista.com/statistics/1313427/china-hpv-vaccine-producer-market-share/
Statista, Market share of major human papillomavirus (HPV) vaccine manufacturers in China in 2022, based on lot release contract price Statista, https://www.statista.com/statistics/1313427/china-hpv-vaccine-producer-market-share/ (last visited December 19, 2024)
Market share of major human papillomavirus (HPV) vaccine manufacturers in China in 2022, based on lot release contract price [Graph], Statista, November 9, 2023. [Online]. Available: https://www.statista.com/statistics/1313427/china-hpv-vaccine-producer-market-share/
